These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27616151)

  • 1. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
    Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic Cortisol-producing Adrenocortical Adenoma Detected by 131I-6β-iodomethyl-norcholesterol Scintigraphy.
    Sato S; Imachi H; Kobayashi T; Fukunaga K; Lyu J; Dong T; Yoshioka Y; Saheki T; Fukata Y; Ban N; Urushihara K; Kadota K; Murao K
    Intern Med; 2020 Jul; 59(14):1731-1734. PubMed ID: 32238722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.
    Shimizu A; Oriuchi N; Tsushima Y; Higuchi T; Aoki J; Endo K
    Ann Nucl Med; 2003 Jul; 17(5):403-6. PubMed ID: 12971640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
    Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
    Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
    Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ
    J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
    Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T
    Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion.
    Kishino M; Yoshimoto T; Nakadate M; Katada Y; Kanda E; Nakaminato S; Saida Y; Ogawa Y; Tateishi U
    Endocr J; 2017 Mar; 64(3):347-355. PubMed ID: 28132968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas.
    Imperiale A; Olianti C; Mannelli M; La Cava G; Pupi A
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):287-96. PubMed ID: 16172575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
    Schteingart DE; Seabold JE; Gross MD; Swanson DP
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
    Geatti O; Fig L; Shapiro B
    Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary adrenocortical nodular dysplasia presented as adrenal adenoma by functional scintigraphy.
    García-Mayor RV; Pérez Mendez L; Páramo C; Andrade A; Guitian R; Butron M
    Clin Nucl Med; 1993 Mar; 18(3):220-2. PubMed ID: 8462213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?
    Charbonnel B; Chatal JF; Ozanne P
    J Nucl Med; 1981 Dec; 22(12):1059-61. PubMed ID: 6273512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of autonomous cortisol secretion in a patient with subclinical Cushing's syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone.
    Sakaguchi C; Ashida K; Kohashi K; Ohe K; Fujii Y; Yano S; Matsuda Y; Sakamoto S; Sakamoto R; Oda Y; Nomura M; Ogawa Y
    BMC Endocr Disord; 2019 Jan; 19(1):13. PubMed ID: 30670014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.